The bacterium E. coli is utilized for synthesizing human insulin through recombinant deoxyribonucleic acid (DNA) technology.
What is Recombinant DNA technology?
Recombinant DNA technology involves the complete methodology of fastening DNA molecules from two different sources and inserting them into a host organism in order to generate products for human use.
Human insulin is synthesized by the action of recombinant DNA within bacteria known as Escherichia coli, which is a Gram-negative, facultatively anaerobic, rod-shaped, coliform bacterium.
The cloned synthetic genes for human insulin A and B are fused to the B-galactosidase gene of E. coli in order to deliver efficient transcription and translation to form a stable protein.
Therefore, the bacterium E. coli is utilized for synthesizing human insulin through recombinant deoxyribonucleic acid (DNA) technology.
To learn more about Recombinant DNA technology, refer to the link:
https://brainly.com/question/5996835
#SPJ4
